Peroxiredoxin 2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB100-40806
Key Product Details
Species Reactivity
Human
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence C-NVDDSKEYFSKHN corresponding to C-Terminus according to NP_005800.3, NP_859427.1.
Reactivity Notes
Expected from sequence similarity: Mouse, Rat
Specificity
This antibody is expected to recognise isoforms a and b only (NP_005800.3 and NP_859427.1 respectively).
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for Peroxiredoxin 2 Antibody
Western Blot: Peroxiredoxin 2 Antibody [NB100-40806]
Western Blot: Peroxiredoxin 2 Antibody [NB100-40806] - Analysis of Peroxiredoxin 2 using this antibody at 1 ug/ml in Human Brain lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.Applications for Peroxiredoxin 2 Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:16000
Western Blot
0.3-1 ug/ml
Application Notes
Western blot: Approx 20-22kDa band observed in Human Brain lysates (calculated MW of 21.9kDa according to NP_005800.3). Primary incubation was 1 hour
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: Peroxiredoxin 2
Alternate Names
NKEF-B, PRDX2, PRX2, TDPX1, TSA
Gene Symbol
PRDX2
UniProt
Additional Peroxiredoxin 2 Products
Product Documents for Peroxiredoxin 2 Antibody
Product Specific Notices for Peroxiredoxin 2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...